Avantor Inc (AVTR)
20.78
+0.42
(+2.09%)
USD |
NYSE |
Nov 22, 16:00
20.78
0.00 (0.00%)
After-Hours: 16:08
Avantor Total Assets (Quarterly): 12.84B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.84B |
| June 30, 2024 | 12.69B |
| March 31, 2024 | 12.76B |
| December 31, 2023 | 12.97B |
| September 30, 2023 | 12.80B |
| June 30, 2023 | 13.06B |
| March 31, 2023 | 13.40B |
| December 31, 2022 | 13.46B |
| September 30, 2022 | 13.11B |
| June 30, 2022 | 13.43B |
| March 31, 2022 | 13.84B |
| December 31, 2021 | 13.90B |
| Date | Value |
|---|---|
| September 30, 2021 | 12.20B |
| June 30, 2021 | 11.25B |
| March 31, 2021 | 9.739B |
| December 31, 2020 | 9.906B |
| September 30, 2020 | 9.938B |
| June 30, 2020 | 9.867B |
| March 31, 2020 | 9.786B |
| December 31, 2019 | 9.773B |
| September 30, 2019 | 9.763B |
| June 30, 2019 | 10.02B |
| March 31, 2019 | 10.01B |
| December 31, 2018 | 9.912B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.739B
Minimum
Mar 2021
13.90B
Maximum
Dec 2021
12.04B
Average
12.78B
Median
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 6.113B |
| Azenta Inc | 2.100B |
| Harvard Bioscience Inc | 131.24M |
| Bionano Genomics Inc | 87.36M |
| Akoya Biosciences Inc | 129.97M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.287B |
| Shareholders Equity (Quarterly) | 5.553B |
| Debt to Equity Ratio | 0.8862 |
| Current Ratio | 1.537 |
| Net Debt Paydown Yield | 1.09% |